122 related articles for article (PubMed ID: 37542520)
1. Endocrine morbidity in neurofibromatosis 1: a nationwide, register-based cohort study.
Kenborg L; Ebbehoj A; Ejerskov C; Handrup MM; Østergaard JR; Hove H; Doser K; Krøyer A; Mulvihill JJ; Winther JF; Stochholm K
Eur J Endocrinol; 2023 Aug; 189(2):190-198. PubMed ID: 37542520
[TBL] [Abstract][Full Text] [Related]
2. Cohort profile: life with neurofibromatosis 1 - the Danish NF1 cohort.
Doser K; Hove H; Østergaard JR; Bidstrup PE; Dalton SO; Handrup MM; Ejerskov C; Krøyer A; Doherty MA; Møllegaard Jepsen JR; Mulvihill JJ; Winther JF; Kenborg L
BMJ Open; 2022 Sep; 12(9):e065340. PubMed ID: 36127120
[TBL] [Abstract][Full Text] [Related]
3. Psychiatric disorders in individuals with neurofibromatosis 1 in Denmark: A nationwide register-based cohort study.
Kenborg L; Andersen EW; Duun-Henriksen AK; Jepsen JRM; Doser K; Dalton SO; Bidstrup PE; Krøyer A; Frederiksen LE; Johansen C; Østergaard JR; Hove H; Sørensen SA; Riccardi VM; Mulvihill JJ; Winther JF
Am J Med Genet A; 2021 Dec; 185(12):3706-3716. PubMed ID: 34327813
[TBL] [Abstract][Full Text] [Related]
4. Increased risk for dementia in neurofibromatosis type 1.
Kallionpää RA; Valtanen M; Auranen K; Uusitalo E; Rinne JO; Peltonen S; Peltonen J
Genet Med; 2021 Nov; 23(11):2219-2222. PubMed ID: 34257422
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcomes in women with neurofibromatosis 1: a Danish population-based cohort study.
Kenborg L; Boschini C; Bidstrup PE; Dalton SO; Doser K; Nielsen TT; Krøyer A; Johansen C; Frederiksen K; Sørensen SA; Hove H; Østergaard JR; Mulvihill JJ; Winther JF
J Med Genet; 2022 Mar; 59(3):237-242. PubMed ID: 33495305
[TBL] [Abstract][Full Text] [Related]
6. Employment, occupation, and income in adults with neurofibromatosis 1 in Denmark: a population- and register-based cohort study.
Kenborg L; Frederiksen LE; Galanakis M; Doser K; Nielsen TT; Doherty MA; Hove H; Østergaard JR; Handrup MM; Ejerskov C; Mulvihill JJ; Winther JF
Orphanet J Rare Dis; 2023 Nov; 18(1):346. PubMed ID: 37932779
[TBL] [Abstract][Full Text] [Related]
7. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
8. The contribution of morbidity and unemployment for the reduced labor market participation of individuals with neurofibromatosis 1 in Finland.
Kallionpää RA; Johansson E; Böckerman P; Peltonen J; Peltonen S
Eur J Hum Genet; 2024 Jan; 32(1):83-90. PubMed ID: 37460655
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study.
Santoro C; Perrotta S; Picariello S; Scilipoti M; Cirillo M; Quaglietta L; Cinalli G; Cioffi D; Di Iorgi N; Maghnie M; Gallizia A; Parpagnoli M; Messa F; De Sanctis L; Vannelli S; Marzuillo P; Miraglia Del Giudice E; Grandone A
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32294191
[TBL] [Abstract][Full Text] [Related]
10. Optic pathway glioma and endocrine disorders in patients with and without NF1.
Gil Margolis M; Yackobovitz-Gavan M; Toledano H; Tenenbaum A; Cohen R; Phillip M; Shalitin S
Pediatr Res; 2023 Jan; 93(1):233-241. PubMed ID: 35538247
[TBL] [Abstract][Full Text] [Related]
11. Forming and ending marital or cohabiting relationships in a Danish population-based cohort of individuals with neurofibromatosis 1.
Kjaer TK; Andersen EW; Olsen M; Kenborg L; Bidstrup PE; Doser K; Hove H; Østergaard JR; Johansen C; Sørensen SA; Mulvihill JJ; Winther JF; Dalton SO
Eur J Hum Genet; 2020 Aug; 28(8):1028-1033. PubMed ID: 32424325
[TBL] [Abstract][Full Text] [Related]
12. Haploinsufficiency of the
Kallionpää RA; Peltonen S; Leppävirta J; Pöyhönen M; Auranen K; Järveläinen H; Peltonen J
J Med Genet; 2021 Jun; 58(6):378-384. PubMed ID: 32571896
[TBL] [Abstract][Full Text] [Related]
13. Multisystem burden of neurofibromatosis 1 in Denmark: registry- and population-based rates of hospitalizations over the life span.
Kenborg L; Duun-Henriksen AK; Dalton SO; Bidstrup PE; Doser K; Rugbjerg K; Pedersen C; Krøyer A; Johansen C; Andersen KK; Østergaard JR; Hove H; Sørensen SA; Riccardi VM; Mulvihill JJ; Winther JF
Genet Med; 2020 Jun; 22(6):1069-1078. PubMed ID: 32107470
[TBL] [Abstract][Full Text] [Related]
14. In-Hospital Clinical Features, Morbidity, and Mortality of Patients with Neurofibromatosis 1 in France: A Nationwide, Population-Based Retrospective Cohort Study.
Diaz E; Bergqvist C; Peiffer B; Fertitta L; Jannic A; Ferkal S; Zehou O; Hemery F; Sbidian E; Wolkenstein P
J Invest Dermatol; 2023 Dec; 143(12):2408-2415.e7. PubMed ID: 37257636
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
Landry JP; Schertz KL; Chiang YJ; Bhalla AD; Yi M; Keung EZ; Scally CP; Feig BW; Hunt KK; Roland CL; Guadagnolo A; Bishop AJ; Lazar AJ; Slopis JM; McCutcheon IE; Torres KE
JAMA Netw Open; 2021 Mar; 4(3):e210945. PubMed ID: 33734413
[TBL] [Abstract][Full Text] [Related]
16. Endocrine Late Effects in Survivors of Cancer in Adolescence and Young Adulthood: A Danish Population-Based Cohort Study.
Jensen MV; Rugbjerg K; de Fine Licht S; Johansen C; Schmiegelow K; Andersen KK; Winther JF
JAMA Netw Open; 2018 Jun; 1(2):e180349. PubMed ID: 30646084
[TBL] [Abstract][Full Text] [Related]
17. Hypertension in NF1: A closer look at the primacy of essential hypertension versus secondary causes.
Loponen N; Ylä-Outinen H; Kallionpää RA; Valtanen M; Auranen K; Järveläinen H; Peltonen S; Peltonen J
Mol Genet Genomic Med; 2024 Jan; 12(1):e2346. PubMed ID: 38131619
[TBL] [Abstract][Full Text] [Related]
18. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
Folkestad L
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
[TBL] [Abstract][Full Text] [Related]
19. Next-generation panel sequencing identifies
Gieldon L; Masjkur JR; Richter S; Därr R; Lahera M; Aust D; Zeugner S; Rump A; Hackmann K; Tzschach A; Januszewicz A; Prejbisz A; Eisenhofer G; Schrock E; Robledo M; Klink B
Eur J Endocrinol; 2018 Feb; 178(2):K1-K9. PubMed ID: 29158289
[TBL] [Abstract][Full Text] [Related]
20. [Type I neurofibromatosis (von Recklinghausen's disease) associated with abdominal neurofibrosarcoma and pheochromocytoma. Apropos of a case].
De Grez T; Lambert M; Delaere B; Gigot JF; Haot J
Acta Clin Belg; 1991; 46(2):89-93. PubMed ID: 1649534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
